Dr. Polydefkis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Avenue
Baltimore, MD 21224Phone+1 410-550-5624Fax+1 410-550-7694
Education & Training
- Johns Hopkins UniversityMHS, Clinical Investigation /Mph, 2005 - 2008
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999
- Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1993 - 1995
- Johns Hopkins University School of MedicineClass of 1993
Certifications & Licensure
- MD State Medical License 1998 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy Start of enrollment: 2013 Mar 15
- Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy.Alexander H Morrison, Maya Hoke, Simone Thomas, Vinay Chaudhry, Michael Polydefkis
Journal of the Peripheral Nervous System. 2024-12-01 - Symptoms of Hereditary Transthyretin Amyloidosis: The Patient and Physician Perspective.Michael Lane, Michael Polydefkis
Neurology and Therapy. 2024-12-01 - Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial.Jonas Wixner, John L Berk, David Adams, Michael Polydefkis, Isabel Conceição
Amyloid. 2024-11-17
Press Mentions
- Spinal Cord Stimulation May Ease Diabetic NeuropathyMarch 1st, 2023
- Golf Is Healthy Exercise for Seniors, Study ConfirmsFebruary 7th, 2023
- Alnylam Gets FDA Backing for Second Generation Onpattro CompetitorJune 14th, 2022
- Join now to see all
Grant Support
- Efficacy And Safety Of Fk1706National Center For Research Resources2007
- Gabapentin And Tramadol In The Treatment Of Small Fiber Predominant NeuropathyNational Center For Research Resources2005–2006
- Topiramate Versus Placebo In A Capsaicin Nerve Injury ModelNational Center For Research Resources2004–2005
- A Trial Of Gabapentin In Restless Legs SyndromeNational Center For Research Resources2004–2005
- Human Axonal Regeneration In Diabetic NeuropathyNational Institute Of Neurological Disorders And Stroke2001–2005
- Models Of Diabetic NeuropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/michael-polydefkis
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: